Acute Intermittent Porphyria PBMC from Sanguine Biosciences

Product Specs
ItemAcute Intermittent Porphyria PBMC
CompanySanguine Biosciences
Price Supplier Page View Company Product Page
Catalog NumberAIP-PBMC-10M
FormatCryopreserved
DiseaseAcute Intermittent Porphyria
Applicationsstudying immune-metabolic interactions, heme biosynthesis disruption, and neuroimmune mechanisms
Quantity5 x 10^6 cells (vial)
Cell TypePBMC

3030 Bunker Hill St, Suite 119

San Diego, CA 92109

United States

Phone: (855) 836-4759

Email: LearnMore@sanguinebio.com

(1) Preclinical Development of a Subcutaneous ALAS1 RNAi Therapeutic for Treatment of Hepatic Porphyrias Using Circulating RNA QuantificationMolecular therapy. Nucleic acidsNovember 3, 2015Chan A, Liebow A, Yasuda M, Gan L, Racie T, Maier M, Kuchimanchi S, Foster D, Milstein S, Charisse K, et al.MD). The same donor-matched matrices and deidentified medical records were obtained from confirmed AIP patients through Sanguine Biosciences (Valencia, CA). SUPPLEMENTARY MATERIAL Table S1. Correlation of

Description